According to the recently published report 'Hepcidin - Pipeline Review, H2 2017'; Hepcidin (Liver Expressed Antimicrobial Peptide 1 or Putative Liver Tumor Regressor or HAMP) pipeline Target constitutes close to 5 molecules. Out of which approximately 5 molecules are developed by Companies.

Hepcidin (Liver Expressed Antimicrobial Peptide 1 or Putative Liver Tumor Regressor or HAMP) - Hepcidin is a protein encoded by the HAMP gene. It acts by promoting endocytosis and degradation of ferroportin leading to the retention of iron in iron exporting cells and decreased flow of iron into plasma. It controls the major flows of iron into plasma, absorption of dietary iron in the intestine and recycling of iron by macrophages.

List of TablesNumber of Products under Development by Stage of Development, H2 2017 7Number of Products under Development by Therapy Areas, H2 2017 8Number of Products under Development by Indication, H2 2017 9Number of Products under Development by Companies, H2 2017 10Products under Development by Companies, H2 2017 11Number of Products by Stage and Mechanism of Actions, H2 2017 13Number of Products by Stage and Route of Administration, H2 2017 15Number of Products by Stage and Molecule Type, H2 2017 17Pipeline by Daiichi Sankyo Co Ltd, H2 2017 18Pipeline by Pieris Pharmaceuticals Inc, H2 2017 19Pipeline by Protagonist Therapeutics Inc, H2 2017 19Dormant Projects, H2 2017 28Discontinued Products, H2 2017 29

List of FiguresNumber of Products under Development by Stage of Development, H2 2017 7Number of Products under Development by Therapy Areas, H2 2017 8Number of Products under Development by Top 10 Indications, H2 2017 9Number of Products by Mechanism of Actions, H2 2017 12Number of Products by Stage and Mechanism of Actions, H2 2017 12Number of Products by Routes of Administration, H2 2017 14Number of Products by Stage and Routes of Administration, H2 2017 14Number of Products by Molecule Types, H2 2017 16Number of Products by Stage and Molecule Types, H2 2017 16